DC Field | Value | Language |
---|---|---|
dc.contributor.author | S H Jung | - |
dc.contributor.author | H S Lee | - |
dc.contributor.author | J S Song | - |
dc.contributor.author | Hwan Mook Kim | - |
dc.contributor.author | Sang Bae Han | - |
dc.contributor.author | Chang Woo Lee | - |
dc.contributor.author | M S Lee | - |
dc.contributor.author | D R Choi | - |
dc.contributor.author | J A Lee | - |
dc.contributor.author | Y H Chung | - |
dc.contributor.author | S J Yoon | - |
dc.contributor.author | Eun Yi Moon | - |
dc.contributor.author | H S Hwang | - |
dc.contributor.author | S K Seong | - |
dc.contributor.author | D K Lee | - |
dc.date.accessioned | 2017-04-19T08:55:35Z | - |
dc.date.available | 2017-04-19T08:55:35Z | - |
dc.date.issued | 1998 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/4508 | - |
dc.description.abstract | Novel 1-(1-benzoylindoline-5-sulfonyl)-4-phenyl-4,5-dihydroimidazolones 3 synthesized show highly potent and broad cytotoxicities. Among them compound 3b (DW2143) exhibits much more potent cytotoxicities than doxorubicin and highly effective antitumor activities against murine (3LL, Colon 26) and human xenograft (NCI-H23, SW620) tumor models. | - |
dc.publisher | Elsevier | - |
dc.title | Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones | - |
dc.title.alternative | Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones | - |
dc.type | Article | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.number | 12 | - |
dc.citation.endPage | 1550 | - |
dc.citation.startPage | 1547 | - |
dc.citation.volume | 8 | - |
dc.contributor.affiliatedAuthor | Hwan Mook Kim | - |
dc.contributor.affiliatedAuthor | Sang Bae Han | - |
dc.contributor.affiliatedAuthor | Chang Woo Lee | - |
dc.contributor.affiliatedAuthor | Eun Yi Moon | - |
dc.contributor.alternativeName | 정상헌 | - |
dc.contributor.alternativeName | 이희순 | - |
dc.contributor.alternativeName | 송재신 | - |
dc.contributor.alternativeName | 김환묵 | - |
dc.contributor.alternativeName | 한상배 | - |
dc.contributor.alternativeName | 이창우 | - |
dc.contributor.alternativeName | 이문순 | - |
dc.contributor.alternativeName | 최동락 | - |
dc.contributor.alternativeName | 이정아 | - |
dc.contributor.alternativeName | 정용호 | - |
dc.contributor.alternativeName | 윤성준 | - |
dc.contributor.alternativeName | 문은이 | - |
dc.contributor.alternativeName | 황현숙 | - |
dc.contributor.alternativeName | 성승규 | - |
dc.contributor.alternativeName | 이덕근 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, vol. 8, no. 12, pp. 1547-1550 | - |
dc.identifier.doi | 10.1016/S0960-894X(98)00261-3 | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.